| Stage | PGEN | % of rev | LLY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $74M | 100.00% | $24.4B | 100.00% | LLY ×329.03 |
| Gross profit | $68M | 91.22% | $20.5B | 83.88% | PGEN +7.3pp |
| Operating income | $39M | 52.13% | $8.6B | 35.28% | PGEN +16.8pp |
| Pre-tax income | $36M | 48.51% | $8.4B | 34.46% | PGEN +14.1pp |
| Net income | $36M | 48.24% | $6.5B | 26.44% | PGEN +21.8pp |
| Stage | PGEN | LLY | Gap · A − B |
|---|---|---|---|
| Revenue | $74M100.00% | $24.4B100.00% | LLY ×329.03 |
| Gross profit | 91.22%$68M | 83.88%$20.5B | PGEN +7.3pp |
| Operating income | 52.13%$39M | 35.28%$8.6B | PGEN +16.8pp |
| Pre-tax income | 48.51%$36M | 34.46%$8.4B | PGEN +14.1pp |
| Net income |
| 48.24%$36M |
| 26.44%$6.5B |
| PGEN +21.8pp |
No shared counterparties.